Recent filings

Guardion Health Sciences, Inc. Just Filed Its Quarterly Report: Loss per Common Shar... - Nov. 10, 2021

Submission of Matters to a Vote of Security - Oct. 25, 2021

On October - Oct. 22, 2021

Termination of a Material Definitive - Sept. 23, 2021

Current report, items 8.01 and 9.01 - Sept. 10, 2021

Guardion Health Sciences, Inc.'s CEO and President just picked up 10,000 shares - Sept. 1, 2021

Guardion Health Sciences, Inc.'s Chief Executive Officer was just granted 916,023 options - Sept. 1, 2021

Guardion Health Sciences, Inc. director just picked up 5,000 shares - Aug. 31, 2021

Guardion Health Sciences, Inc. director just picked up 1,500 shares - Aug. 31, 2021

Guardion Health Sciences, Inc. releases salary data. CEO sees compensation fall -91% - Aug. 25, 2021

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - Aug. 25, 2021

Departure of Directors or Certain - Aug. 24, 2021

Guardion Health Sciences, Inc. director just picked up 10,000 shares - Aug. 23, 2021

Guardion Health Sciences Announces Financial Results - Aug. 16, 2021

Guardion Health Sciences, Inc. Just Filed Its Quarterly Report: Loss per Common Shar... - Aug. 16, 2021

Guardion Health Sciences: Those Charged With Governance - Aug. 10, 2021

Guardion Health Sciences: Those Charged With Governance - Aug. 10, 2021

Guardion Health Sciences, Inc.'s Chief Accounting Officer just declared ownership of no shares of Guardion Health Sciences, Inc. - Aug. 2, 2021

Departure of Directors or Certain - Aug. 2, 2021

Guardion Health Sciences, Inc. director was just granted 16,667 options - July 2, 2021

Guardion Health Sciences, Inc. director was just granted 16,667 options - July 2, 2021

Guardion Health Sciences, Inc. director was just granted 16,667 options - July 2, 2021

Guardion Health Sciences, Inc. director was just granted 16,667 options - July 2, 2021

Current report, items 7.01 and 9.01 - June 9, 2021

Statement of changes in beneficial ownership of securities - June 4, 2021

Guardion Health Sciences Broadens Clinical Nutrition Product Offerings By Closing Acquisition Of Activ Nutritional, Which Owns The Science Backed, Revenue-Generating Viactiv® Product Line, From Adare - June 4, 2021

Guardion Health Sciences, Inc.'s Chief Commercial Officer just declared ownership of no shares of Guardion Health Sciences, Inc. - June 4, 2021

Departure of Directors or Certain - May 24, 2021

Current report, items 1.01, 8.01, and 9.01 - May 21, 2021

Guardion Health Sciences Announces Financial Results - May 17, 2021

Quarterly report [Sections 13 or 15(d)] - May 17, 2021

Current report, items 8.01 and 9.01 - May 3, 2021

Securities to be offered to employees in employee benefit plans - April 7, 2021

Guardion Health Sciences Announces Financial Results - March 26, 2021

Annual report [Section 13 and 15(d), not S-K Item 405] - March 26, 2021

Guardion Health Sciences Regains Compliance With Nasdaq Minimum Bid Price Rule - March 16, 2021

Guardion Health Sciences Announces 1-For-6 Reverse Stock Split - March 1, 2021

Edward B. Grier III just provided an update on share ownership of Guardion Health Sciences, Inc. - Feb. 12, 2021

Guardion Health Sciences, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Jan. 28, 2021

Entry into a Material Definitive - Jan. 28, 2021

Nasdaq Grants Guardion Health Sciences An Extension To - Jan. 27, 2021

Guardion Health Sciences, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Jan. 8, 2021

Entry into a Material Definitive - Jan. 8, 2021

Guardion Health Sciences, Inc.'s CHIEF EXECUTIVE OFFICER just picked up 916,023 shares - Jan. 6, 2021

Guardion Health Sciences, Inc.'s Chief Executive Officer just declared owning 1,016,900 shares of Guardion Health Sciences, Inc. - Jan. 6, 2021

Guardion Health Sciences Appoints Seasoned Nutritional Products - Dec. 29, 2020

Sorry, no schedule available for this company

Guardion Health Sciences Announces Financial Results for the Three Months Ended September 30, 2021 - Nov. 10, 2021

Guardion Health Sciences to Present at the Benzinga Global Small Cap Conference - Oct. 25, 2021

Guardion Health Sciences Stockholders Urged to Vote Their Shares for October 22, 2021 Annual Meeting - Oct. 12, 2021

Guardion Health Sciences to Present at the LD Micro Main Event Conference - Oct. 5, 2021

Guardion Health Sciences to Present at the Benzinga Healthcare Small Cap Conference - Sept. 27, 2021

Guardion Health Sciences Announces Financial Results for the Three Months Ended June 30, 2021, including $1,000,000+ of Sales from Viactiv® Products in the First Month of Guardion’s Ownership - Aug. 16, 2021

Guardion Health Sciences to Exhibit at the American Society of Cataract and Refractive Surgery Annual Meeting - July 22, 2021

Guardion Health Sciences to Be Added to the Russell 3000 Index - June 14, 2021

Guardion Health Sciences Announces Appointment of Craig J. Sheehan as Chief Commercial Officer - June 3, 2021

Guardion Health Sciences Broadens Clinical Nutrition Product Offerings by Closing Acquisition of Activ Nutritional, which owns the Science Backed, Revenue-Generating Viactiv® Product Line, from Adare Pharmaceuticals - June 2, 2021

Guardion Health Sciences to Present at the LD Micro Virtual Invitational Conference on June 9, 2021 - June 2, 2021

Guardion Health Sciences to Acquire Activ Nutritional, LLC and Its Well-Known Viactiv® Brand of Products from Adare Pharmaceuticals, Inc. - May 18, 2021

Guardion Health Sciences Initiates Placebo-Controlled Clinical Trial Involving Proprietary GlaucoCetin® Product - May 3, 2021

Guardion Health Sciences Announces Financial Results for the Three Months and Year Ended December 31, 2020 - March 26, 2021

Guardion Health Sciences Regains Compliance with Nasdaq Minimum Bid Price Rule - March 16, 2021

Guardion Health Sciences Announces 1-for-6 Reverse Stock Split Effective Pre-Market Opening on Monday, March 1, 2021 - Feb. 26, 2021

Malaysia’s Ho Wah Genting Berhad Advises Guardion Health Sciences That It Has received Regulatory Product Registration Approval for Second Immune Support Dietary Supplement Designed and Produced by Guardion Health Sciences - Jan. 28, 2021

Nasdaq Grants Guardion Health Sciences an Extension to March 15, 2021 to Regain Compliance with the $1.00 Minimum Bid Price Rule - Jan. 27, 2021

Guardion Health Sciences Appoints Seasoned Nutritional Products Industry Leader Bret Scholtes as President and Chief Executive Officer - Dec. 28, 2020

Guardion Health Sciences Announces Development of New Vision/Energy Support Drink – EPIQ-V - Dec. 16, 2020